Alto Neuroscience, Inc. — Form D
Alto Neuroscience, Inc. of MOUNTAIN VIEW, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-11-27. The offering totals $45.0M, of which $45.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-11-27
- Form: D
- Accession: 0001999480-23-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $45.0M
- Investors: 16
- Date of first sale: 2023-11-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498128
Issuer
- Name: Alto Neuroscience, Inc.
- CIK: 0001999480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Phone: (650) 200-0412
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Po Yu (Jeff) Chen | Director | Los Altos, CA |
| Chris Nixon Dimitropoulos | Director | Los Altos, CA |
| Michael Nixon Liang | Director | Los Altos, CA |
| Aaron Weaver | Director | Irvine, CA |
| Gwill York | Director | Los Altos, CA |
| Nicholas Smith | Executive Officer | PLYMOUTH, MN |
| Adam Savitz | Executive Officer | Mountain View, CA |
| Amit Etkin | Director | Mountain View, CA |
| Amit Etkin | Executive Officer | Mountain View, CA |
| Nicholas C Smith | Executive Officer | Mountain View, CA |
| Gwill C York | Director | Mountain View, CA |
| Husseini Nixon Manji | Director | Mountain View, CA |
| Christopher Nixon Cox | Director | Mountain View, CA |
| Raymond Nixon Sanchez | Director | Mountain View, CA |
| Andrew Nixon Dreyfus | Director | Mountain View, CA |
| Michael Hanley | Executive Officer | Mountain View, CA |
Other filings by this issuer (4)
More